News

Published on 6 Mar 2024 on Benzinga

Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday -...

Article preview image

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

 

Read the rest of the article
NYSE.COOK price evolution
NASDAQ.MCRB price evolution
NYSE.TWLO price evolution
NYSE.EMR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now

Key Insights Seres Therapeutics' Annual General Meeting to take place on 4th of AprilCEO Eric Sha...

Simply Wall St. via Yahoo Finance 29 Mar 2024
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript March 5, 2024 Seres Thera...

Insider Monkey via Yahoo Finance 7 Mar 2024
Earnings call: Seres Therapeutics reports promising VOWST launch By Investing.com

Seres Therapeutics, Inc. (NASDAQ:MCRB) has announced a successful year marked by the approval and...

Investing.com 6 Mar 2024
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday -...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 6 Mar 2024
Earnings call: Seres Therapeutics reports promising VOWST launch

Seres Therapeutics, Inc. (NASDAQ: MCRB ) has announced a successful year marked by the approval a...

Investing.com 5 Mar 2024
Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023

Net Sales: VOWST achieved $10.4 million in Q4 and $19.6 million in H2 2023 sales.Net Loss Reducti...

GuruFocus.com via Yahoo Finance 5 Mar 2024
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62%

Key Insights Given the large stake in the stock by institutions, Seres Therapeutics' stock price ...

Simply Wall St. via Yahoo Finance 2 Dec 2023
Seres cuts its workforce by nearly half, focuses on FDA-approved drug - Boston Business Journal

Seres Therapeutics Inc. is making big cuts to its workforce as it prioritizes the commercial laun...

The Business Journals 6 Nov 2023
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript November 4, 2023 Operator...

Insider Monkey via Yahoo Finance 5 Nov 2023
Nasdaq Gains 1%; US Adds 150,000 Jobs In October - Cooper-Standard Holdings (NYSE:CPS), BILL ...

U.S. stocks traded higher this morning, following the release of jobs report for October. Followi...

Benzinga 4 Nov 2023

Copyright Statfolio @ 2024

Social Accounts